Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Thrombocytopenia Purpura”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03164915
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
SK Plasma Co., Ltd. 37
Testing effectiveness (Phase 2)Looking for participantsNCT07362238
What this trial is testing

Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 122
Large-scale testing (Phase 3)Looking for participantsNCT07194850
What this trial is testing

Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia (ITP)ITP - Immune ThrombocytopeniaITP+4 more
argenx 24
Large-scale testing (Phase 3)Study completedNCT02279173
What this trial is testing

Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Amgen 203
Early research (Phase 1)Not Yet RecruitingNCT07622329
What this trial is testing

A Clinical Study to Evaluate JCXH-213 in the Treatment of Adults With Primary Immune Thrombocytopenia

Who this might be right for
Thrombocytopenic Purpura, Immune
The General Hospital of Western Theater Command 4
Post-approval studies (Phase 4)Study completedNCT01957176
What this trial is testing

A Rollover Study to Provide Continued Treatment With Eltrombopag

Who this might be right for
Thrombocytopaenia
Novartis Pharmaceuticals 22
Testing effectiveness (Phase 2)UnknownNCT05943691
What this trial is testing

High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Who this might be right for
ITP - Immune Thrombocytopenia
Shandong University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05023915
What this trial is testing

Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 106
Testing effectiveness (Phase 2)Study completedNCT00625443
What this trial is testing

Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Eisai Inc. 53
Post-approval studies (Phase 4)Study completedNCT00467571
What this trial is testing

Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura

Who this might be right for
Chronic Idiopathic Thrombocytopenic PurpuraHelicobacter Pylori Infection
Mahidol University 26
Post-approval studies (Phase 4)Study completedNCT01390649
What this trial is testing

A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenic Purpura
CSL Behring 57
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07057778
What this trial is testing

Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Peking University People's Hospital 120
Large-scale testing (Phase 3)Study completedNCT02063789
What this trial is testing

An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Green Cross Corporation 81
Very early researchLooking for participantsNCT07441525
What this trial is testing

UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases

Who this might be right for
Autoimmune Hemolytic AnemiaPrimary Immune Thrombocytopenic PurpuraEvans Syndrome
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 27
Large-scale testing (Phase 3)Not Yet RecruitingNCT07051915
What this trial is testing

The Holistic Study

Who this might be right for
Thrombocytopenia Purpura
Ostfold Hospital Trust 220
Testing effectiveness (Phase 2)Study completedNCT01713738
What this trial is testing

Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)Immune Thrombocytopenic Purpura (ITP)
Neufeld, Ellis J, MD, PhD 36
Testing effectiveness (Phase 2)Ended earlyNCT01129024
What this trial is testing

An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Shionogi 19
Testing effectiveness (Phase 2)UnknownNCT03909763
What this trial is testing

Combination of Danazole With Berberine in the Treatment of ITP

Who this might be right for
Corticosteroid-resistant or Relapsed ITP
Peking University People's Hospital 55
Testing effectiveness (Phase 2)UnknownNCT04516837
What this trial is testing

Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 120
Testing effectiveness (Phase 2)Study completedNCT00621894
What this trial is testing

Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation

Who this might be right for
Immune Thrombocytopenic Purpura
GlaxoSmithKline 23
Next Page